Nanalysis Scientific Corp. Signs Strategic OEM Partnership for Magnetic Resonance Electronics Sales

About this update from Nanalysis Scientific Corp

[{"type":"text","content":"\n \n \n \n Nanalysis Scientific Corp. Signs Strategic OEM Partnership for Magnetic Resonance Electronics Sales\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n CALGARY, AB\n \n ,\n \n Jan. 12, 2021\n \n /CNW/ -\n \n Nanalysis Scientific Corp.\n \n (\"Nanalysis\"),(\n \n TSXV: NSCI\n \n ) (\n \n OTCQX: NSCIF\n \n ) (\n \n FRA: 1N1\n \n ), through its subsidiary RS2D S.A.S. (\"RS2D\"), is pleased to announce that it has signed multi-million dollar OEM and licensing deal with a European corporation.\n \n \n \n Rémy Schimpf\n \n , Senior VP Sales states \"The deal includes an initial payment of roughly\n \n $1 million\n \n , and a further\n \n $2 million\n \n in milestone payments over the next three years. In addition, there is the strong potential for revenue through OEM sales in subsequent years an order of magnitude larger. Nanalysis retains the ownership of intellectual property and has ingredient branding rights. Although this partner cannot be named at this time for competition reasons, the partner has tremendous experience and a successful track record in commercial magnetic resonance systems.\n \n \n \"This partnership includes our Cameleon4 electronics technology platform along with our next gen application software, specifically developed for areas such as molecular imaging, MRI physics, and virology. The Cameleon4 is also used in our benchtop NMR, high-field NMR, and MRI products, Our OEM licensing partner will combine our electronics and software technologies with several other hardware and software modules to produce a novel, integrated solution for new and existing magnetic resonance life science markets globally.\"\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Sean Krakiwsky\n \n \n , founder and CEO of Nanalysis Scientific adds, \"We continue to leverage the technology we acquired to generate short term revenue, medium term market opportunities, and achieve our long-term vision. We are working with quality partners who have a proven track record and complementary visions for the future of MRI and NM...

More updates from Nanalysis Scientific Corp